Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin

BACKGROUND: Persistence with lipid-lowering drug use is important in order for patients to gain full treatment benefit. The withdrawal of cerivastatin from the market may have affected persistence due to the fear of serious adverse effects. OBJECTIVE: To assess failure of patients to continue lipid-lowering drug use following the withdrawal of cerivastatin. METHODS: A cohort study including 3.5 months follow-up after the withdrawal of cerivastatin in August 2001 was conducted using data from community pharmacies in The Netherlands, covering a population of approximately 600,000 subjects. Patie... Mehr ...